Genetic analysis of SS18L1 in French amyotrophic lateral sclerosis

Neurobiology of Aging

Volumn 35, Issue 5, 2014, Pages 1213.e9-1213.e12

  Teyssou, Elisa ^a   Vandenberghe, Nadia ^b   Moigneu, Carine ^a   Boillée, Séverine ^a   Couratier, Philippe ^c   Meininger, Vincent ^d   Pradat, Pierre François ^d,e   Salachas, François ^d   LeGuern, Eric ^a,d   Millecamps, Stéphanie ^a  

^a INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^b HÔPITAL NEUROLOGIQUE   (France)

^c UNIVERSITÉ DE LIMOGES   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e INSERM   (France)

Author keywords

Amyotrophic lateral sclerosis; CREST; Double mutant; Familial ALS; Genetic analysis; Motor neuron disease; OPTN

Indexed keywords

ADENINE; ALANINE; ARGININE; GLUTAMINE; GUANINE; ISOLEUCINE; LEUCINE; METHIONINE; SERINE; THREONINE; THYMINE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; DENDRITIC CELL; DISEASE DURATION; ETHNIC GROUP; EXOME; EXON; FRENCH LANGUAGE; GENE; GENE DELETION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NERVE FIBER GROWTH; NUCLEOTIDE SEQUENCE; ONSET AGE; OPTN GENE; PHENOTYPE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SS18L1 GENE; VERY ELDERLY;

AMYOTROPHIC LATERAL SCLEROSIS; CREST; DOUBLE MUTANT; FAMILIAL ALS; GENETIC ANALYSIS; MOTOR NEURON DISEASE; OPTN;

AGED; AGED, 80 AND OVER; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; BASE SEQUENCE; CHICKENS; DENDRITES; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXONS; FRANCE; GENETIC VARIATION; HUMANS; MACACA MULATTA; MICE; MOLECULAR SEQUENCE DATA; MUTATION; RATS; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR TFIIIA;

EID: 84893715551     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.11.023     Document Type: Article

References (13)

1. Andersen P.M., Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know?. Nat. Rev. Neurol. 2011, 7:603-615.
2. Chesi A., Staahl B.T., Jovicic A., Couthouis J., Fasolino M., Raphael A.R., Yamazaki T., Elias L., Polak M., Kelly C., Williams K.L., Fifita J.A., Maragakis N.J., Nicholson G.A., King O.D., Reed R., Crabtree G.R., Blair I.P., Glass J.D., Gitler A.D. Exome sequencing to identify de novo mutations in sporadic ALS trios. Nat. Neurosci. 2013, 16:851-855.
3. Gitler A.D., Shorter J. RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion 2011, 5:179-187.
4. Lattante S., Conte A., Zollino M., Luigetti M., Del Grande A., Marangi G., Romano A., Marcaccio A., Meleo E., Bisogni G., Rossini P.M., Sabatelli M. Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease. Neurology 2012, 79:66-72.
5. Maruyama H., Morino H., Ito H., Izumi Y., Kato H., Watanabe Y., Kinoshita Y., Kamada M., Nodera H., Suzuki H., Komure O., Matsuura S., Kobatake K., Morimoto N., Abe K., Suzuki N., Aoki M., Kawata A., Hirai T., Kato T., Ogasawara K., Hirano A., Takumi T., Kusaka H., Hagiwara K., Kaji R., Kawakami H. Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010, 465:223-226.
6. Millecamps S., Da Barroca S., Cazeneuve C., Salachas F., Pradat P.F., Danel-Brunaud V., Vandenberghe N., Lacomblez L., Le Forestier N., Bruneteau G., Camu W., Brice A., Meininger V., LeGuern E. Questioning on the role of D amino acid oxidase in familial amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U.S.A 2010, 107:E107. author reply E108.
7. Millecamps S., Corcia P., Cazeneuve C., Boillee S., Seilhean D., Danel-Brunaud V., Vandenberghe N., Pradat P.F., Le Forestier N., Lacomblez L., Bruneteau G., Camu W., Brice A., Meininger V., LeGuern E., Salachas F. Mutations in UBQLN2 are rarein French amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33:839.e1-839.e3.
8. Millecamps S., Boillee S., Chabrol E., Camu W., Cazeneuve C., Salachas F., Pradat P.F., Danel-Brunaud V., Vandenberghe N., Corcia P., Le Forestier N., Lacomblez L., Bruneteau G., Seilhean D., Brice A., Feingold J., Meininger V., LeGuern E. Screening of OPTN in French familial amyotrophic lateral sclerosis. Neurobiol. Aging 2011, 32:557.e11-557.e13.
9. Millecamps S., Boillee S., Le Ber I., Seilhean D., Teyssou E., Giraudeau M., Moigneu C., Vandenberghe N., Danel-Brunaud V., Corcia P., Pradat P.F., Le Forestier N., Lacomblez L., Bruneteau G., Camu W., Brice A., Cazeneuve C., Leguern E., Meininger V., Salachas F. Phenotype difference between ALS patients with expanded repeats in C9ORF72 and patients with mutations in other ALS-related genes. J.Med. Genet. 2012, 49:258-263.
10. Millecamps S., Salachas F., Cazeneuve C., Gordon P., Bricka B., Camuzat A., Guillot-Noel L., Russaouen O., Bruneteau G., Pradat P.F., Le Forestier N., Vandenberghe N., Danel-Brunaud V., Guy N., Thauvin-Robinet C., Lacomblez L., Couratier P., Hannequin D., Seilhean D., Le Ber I., Corcia P., Camu W., Brice A., Rouleau G., Leguern E., Meininger V. SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J.Med. Genet. 2010, 47:554-560.
11. Rezaie T., Child A., Hitchings R., Brice G., Miller L., Coca-Prados M., Heon E., Krupin T., Ritch R., Kreutzer D., Crick R.P., Sarfarazi M. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 2002, 295:1077-1079.
12. Teyssou E., Takeda T., Lebon V., Boillee S., Doukoure B., Bataillon G., Sazdovitch V., Cazeneuve C., Meininger V., Leguern E., Salachas F., Seilhean D., Millecamps S. Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol 2013, 125:511-522.
13. van Blitterswijk M., Baker M.C., Dejesus-Hernandez M., Ghidoni R., Benussi L., Finger E., Hsiung G.Y., Kelley B.J., Murray M.E., Rutherford N.J., Brown P.E., Ravenscroft T., Mullen B., Ash P.E., Bieniek K.F., Hatanpaa K.J., Karydas A., McCarty Wood E., Coppola G., Bigio E.H., Lippa C., Strong M.J., Beach T.G., Knopman D.S., Huey E.D., Mesulam M., Bird T., White C.L., Kertesz A., Geschwind D.H., Van Deerlin V.M., Petersen R.C., Binetti G., Miller B.L., Petrucelli L., Wszolek Z.K., Boylan K.B., Graff-Radford N.R., Mackenzie I.R., Boeve B.F., Dickson D.W., Rademakers R. C9ORF72 repeat expansionsincases with previously identified pathogenic mutations. Neurology 2013, 81:1332-1341.